A Crystal Ball For Drug Launch Success? Try Consensus Estimates
This article was originally published in The Pink Sheet Daily
Executive Summary
Consensus estimates can be a predictor of how a biopharma will perform during a drug launch, a Leerink Swann report shows, citing examples from the last ten years as proof.